Prevention committee

ESGO Prevention committee

The Prevention Committee was established in 2019 to fulfil the ESGO vision: Best treatment and prevention in gynaecological cancer. ESGO has set as its mission to improve the health and well-being of women with gynaecological cancers through prevention, research, excellence in care and education. The Prevention Committee is therefore one of the cornerstones to ensure the fulfilment of its mission.

The Chair of the Prevention Committee is Prof. Murat Gultekin.

 

The Prevention Committee has set as its goals to:

  • Facilitate systematic research, issue scientific publications, and disseminate findings in the prevention and treatment of pre-invasive diseases.
  • Raise public and governmental awareness and advocate about gynaecological cancers, their prevention and treatment through ENGAGe.
  • Collaborate with professional societies, patient advocacy organisations, policymakers and other stakeholders to advance gynaecological cancers prevention and care.
  • Contribute to cervical cancer elimination in Europe in line with the WHO elimination programme 2030. Decrease mortality and extend life of gynaecological cancer patients in line with the EU Beat the cancer plan.

World Health Organization has launched ''Cervical Cancer Elimination Program'' on November 19, 2020.

The program asks the countries to vaccinate the girls under 15 years of age (90% coverage), to screen females by minimal two times when they are 35 and 45 (70%) coverage and to treat the lesions detected appropriately (in 90% of cases).

Modelling studies show that if all countries can implement the program until 2030 and can achieve these targets, there will be a 30% reduction in cervical cancer mortality by 2030 and the cervical cancer may be eliminated until the end of this century (namely incidence less than 4 \ 100.000).

 

ESGO Prevention committee has joined in to fulfil the WHO cervical cancer elimination strategy as a leading European actor in prevention.

Committee Structure

Prevention Committee Chair: Murat Gultekin

 

Members:

Marc Arbyn, Andreas Ullrich, Elmar Joura, Maria Kyrgiou, Jalid Sehouli, Nadja Taumberger (ENYGO), Ico Toth (ENGAGe), Esra Urkmez (Fundraising)

Publications

2021 Publications:

  • 2020 ESGO list of HPV assays that can be used for cervical cancer screening, M. Arbyn, M. Gultekin.
  • Gynaecologic oncology on the global health agenda: A wake-up call. Gynaecologic Oncology.
  • HPV Prevention and Control – the way forward, The Lancet (in process of publication)
  • Self-tests in pregnant women (in process of publication)

 

2020 Publications:

 

2019 Publications:

Ongoing scientific projects

  • ESGO involvement in the Horizon 2020 RISCC project.
  • ESGO requirements on HPV assays usable in cervical cancer screening (Marc Arbyn, Sciensano).
  • ESGO principles for triage tests or combination of triage tests (Marc Arbyn, Sciensano).
  • Assessment of Conisation.
  • Consensus statement on pre-invasive vulvar and vaginal disease (in collaboration with EFC, ESP, ISSVD and ECSVD).

Prevention Committee webinars

Webinars 2021:

  • Cervical cancer elimination - is it possible or not? - for Doctors, June 2021.

For recordings go to ESGO eAcademy portal. You need to register to access.

  • Cervical cancer elimination - is it possible or not? - for Patients, June 2021.

For recordings please go to the ENGAGe YouTube channel.

 

Webinars 2020:

  • Management of cancer patients during the Covid-19 pandemic, September 2020.

Educational events participation

National Cancer Control Plan conference, Bulgaria, 16/9/2021

ESGO Prevention Committee member Dr. Andreas Ullrich is invited as a speaker for the NCCP conference hosted by the Parliamentary Health Commission held at the National Assembly in Bulgaria on 16th September 2021.

 

HPV Awareness event, Bulgaria, 22/7/2021

ESGO Prevention Committee collaborates with the European Parliamentary Forum (EPF) and joins forces together to boost awareness in HPV prevention across Europe. Together with Bulgaria’s National Information Campaign for the Prevention of Human Papilloma Virus the EPF organised an Awareness event in Bulgaria and invited our member, Dr. Maria Kyrgiou (UK) as a European expert on HPV.

Prevention Committee awards

Dr. Murat Gultekin was awarded the IGCS Distinguished Advocacy Award for his extensive and tireless efforts to unify advocacy NGOs throughout Europe, forming ENGAGe. As the leading founder of HPV DNA Screening, Mobile Trucks and Central Mammography Report Unit, cancer registry systems and community- based palliative care system he is partly responsible for major innovations in cancer screening in Turkey and around the world. For more info visit the IGCS website.